Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only

NCT06867705 · tracked via the Priya Life Science Germany tracker

Sponsor

Resilience

Phase

Phase 3

Started

2025-04-01

Last updated

2026-04-03

Condition(s) studied

Cancer

Investigational drug(s) / intervention(s)

Resilience PRO

Resilience PRO: The patient will use Resilience PRO remote symptoms monitoring.

Study summary

The goal of this clinical trial is to learn if Resilience PRO, a digital solution performing remote symptoms monitoring, can improve the quality of life of patients with a diagnosis of cancer receiving systemic anticancer treatment.

The main question it aims to answer is:

\- Do patients with a diagnosis of cancer receiving systemic anticancer therapy and using Resilience PRO have an improved quality of life? Researchers will compare patients using Resilience PRO plus care as usual to patients receiving care as usual only.

Participants in the intervention arm will use Resilience PRO, a mobile phone application regularly asking participants about their symptoms. For clinically important symptoms, an alert is sent to the care team that can incorporate that information to timely adjust the care of the participants. Participants both in the control arm and in the intervention arm will further receive care as usual.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Age: Adults ≥ 18 years. * Informed Consent: Patient giving signed informed consent to participate in the RC - 102 clinical study. * Diagnosis: Patients with cancer at any stage. * Systemic Treatment * Remote Monitoring Eligibility: Access to a smartphone * Language: Ability to understand and communicate in the language(s) in which the trial is conducted. Exclusion Criteria: * Age: Patients under 18 years of age. * Life Expectancy: Patients with a life expectancy of less than 6 months as estimated by the treating physician. * Concurrent remote monitoring * HSCT or CAR-T Therapy * Cognitive Impairment * Pregnancy or breastfeeding * Subject under administrative or judicial control

Primary outcome measure(s)

Health-Related quality of life — 3 months
EORTC QLQ-C30

Trial sites (36)

Facility	City	Region	Status
Hôpital Privé de Provence	Aix-en-Provence	France	Recruiting
Centre Hospitalier du Pays d'Aix - Centre Hospitalier Intercommunal Aix-Pertuis	Aix-en-Provence	France	Recruiting
Centre Hospitalier Henri Mondor-Aurillac	Aurillac	France	Recruiting
Centre Hospitalier de la Côte Basque	Bayonne	France	Recruiting
Centre Hospitalier Universitaire de Caen Normandie	Caen	France	Recruiting
Centre Hospitalier Universitaire de Clermont-Ferrand	Clermont-Ferrand	France	Recruiting
Centre Hospitalier Universitaire Grenoble - Alpes	La Tronche	France	Recruiting
GHICL Hôpital Saint Vincent de Paul	Lille	France	Recruiting
Centre Hospitalier Universitaire de Lille	Lille	France	Recruiting
Hôpital Privé Jean Mermoz - Institut de Cancérologie	Lyon	France	Recruiting
AP-HM Assistance Publique - Hôpitaux de Marseille Hôpital de la Timone	Marseille	France	Recruiting
Centre Hospitalier Universitaire de Nantes	Nantes	France	Recruiting
Hôpital Privé du Confluent	Nantes	France	Recruiting
Centre Hospitalier Universitaire de Nice	Nice	France	Recruiting
Centre Hospitalier Universitaire de Nîmes	Nîmes	France	Recruiting
AP-HP Hôpitaux Universitaires La Pitié Salpêtrière	Paris	France	Recruiting
Clinique Mutualiste Bretagne Occidentale	Quimper	France	Recruiting
Hôpital Privé de la Loire (HPL) - Saint Etienne	Saint-Etienne	France	Recruiting
Clinique Mutualiste de l'Estuaire	Saint-Nazaire	France	Recruiting
Centre Hospitalier Universitaire Sud Réunion	Saint-Pierre	France	Recruiting
Centre Clinical Elsan	Soyaux	France	Recruiting
Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer	Toulon	France	Recruiting
Clinique Pasteur	Toulouse	France	Recruiting
Centre de Cancérologie Les Dentellières	Valenciennes	France	Recruiting
Clinique Teissier	Valenciennes	France	Recruiting
Gustave Roussy	Villejuif	France	Recruiting
University Hospital Augsburg - UKA	Augsburg	Germany	Recruiting
Helios Klinikum Bad Saarow	Bad Saarow	Germany	Recruiting
Katholisches Klinikum Bochum UK St. Josef - Hospital	Bochum	Germany	Recruiting
UK Hamburg- Eppendorf (UKE)	Hamburg	Germany	Recruiting
Medizinische Hochschule Hannover	Hanover	Germany	Recruiting
MVZ Aschaffenburg-Alzenau	Hösbach	Germany	Recruiting
Universitätsklinikum Schleswig-Holstein (UKSH), Campus Kiel	Kiel	Germany	Recruiting
Universitätsklinikum Schleswig-Holstein (UKSH), Campus Lübeck	Lübeck	Germany	Recruiting
Onkomedeor MVZ Perlach	München	Germany	Recruiting
Universitätsklinikum Tuebingen	Tübingen	Germany	Recruiting

Other trials for the same condition

Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases Recruiting

Pan Tumor Rollover Study Recruiting

Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries. Recruiting

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor Active, not recruiting

Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-oriented Exercise Therapy for Oncological Patients Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06867705 on ClinicalTrials.gov ↗ ← All trials in Germany